- Home
- CFFN vs KURA Comparison
CFFN vs KURA Comparison
Compare CFFN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFN
- KURA
- Stock Information
- Founded
- CFFN 1893
- KURA 2014
- Country
- CFFN United States
- KURA United States
- Employees
- CFFN N/A
- KURA N/A
- Industry
- CFFN Savings Institutions
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFFN Finance
- KURA Health Care
- Exchange
- CFFN Nasdaq
- KURA Nasdaq
- Market Cap
- CFFN 813.3M
- KURA 700.5M
- IPO Year
- CFFN 1999
- KURA N/A
- Fundamental
- Price
- CFFN $6.55
- KURA $8.13
- Analyst Decision
- CFFN Hold
- KURA Buy
- Analyst Count
- CFFN 1
- KURA 14
- Target Price
- CFFN $6.50
- KURA $24.45
- AVG Volume (30 Days)
- CFFN 586.3K
- KURA 1.9M
- Earning Date
- CFFN 10-22-2025
- KURA 08-07-2025
- Dividend Yield
- CFFN 5.25%
- KURA N/A
- EPS Growth
- CFFN N/A
- KURA N/A
- EPS
- CFFN 0.47
- KURA N/A
- Revenue
- CFFN $192,483,000.00
- KURA $83,279,000.00
- Revenue This Year
- CFFN $10.56
- KURA $60.25
- Revenue Next Year
- CFFN $11.73
- KURA $155.10
- P/E Ratio
- CFFN $13.78
- KURA N/A
- Revenue Growth
- CFFN N/A
- KURA N/A
- 52 Week Low
- CFFN $4.90
- KURA $5.41
- 52 Week High
- CFFN $7.20
- KURA $21.40
- Technical
- Relative Strength Index (RSI)
- CFFN 67.38
- KURA 65.48
- Support Level
- CFFN $6.34
- KURA $7.86
- Resistance Level
- CFFN $6.53
- KURA $8.48
- Average True Range (ATR)
- CFFN 0.12
- KURA 0.48
- MACD
- CFFN 0.03
- KURA 0.09
- Stochastic Oscillator
- CFFN 100.00
- KURA 75.16
About CFFN Capitol Federal Financial Inc.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank, Capitol Federal Savings Bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It primarily serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.